Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expansion and Infusion of T-Regulatory Cells in Amyotrophic Lateral Sclerosis
NCT03241784Phase 1Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- May 2016
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in amyotrophic lateral sclerosis (ALS), sponsored by Houston Methodist Research Institute. Primary endpoint: Treatment-related Adverse Events up to 2 years. Started May 2016; status: completed.
02
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03241784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03241784.